Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
September 21, 2007

European Medicines Agency Recommends Approval of Liver Cancer Drug

  • Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals report that an advisory panel to the European Commission issued a positive review of the companies’ liver cancer drug for approval.

    The European Committee for Medicinal Products for Human Use recommended that Nexavar be granted marketing authorization for the treatment of patients with hepatocellular carcinoma.

    Nexavar is under priority review at the FDA. The drug is already marketed in over 50 countries including the U.S. for the treatment of advanced kidney cancer, according to the firms.

  • You’re all set! Thank you for subscribing to GEN Highlights.